Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Lycke

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Molecular Medicine|September 24, 2005
Targeted vaccine adjuvants based on modified cholera toxinNils Lycke
Nature Reviews. Immunology|July 26, 2012
Recent progress in mucosal vaccine development: potential and limitationsNils Lycke
Cellular Microbiology|December 18, 2003
From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOMNils Lycke
Immunology Letters|March 9, 2005
From toxin to adjuvant: basic mechanisms for the control of mucosal IgA immunity and toleranceNils Lycke
Annals of the New York Academy of Sciences|February 1, 2005
ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunityNils Lycke
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
A unique population of extrathymically derived alpha beta TCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tractMartina Johansson, Nils Lycke
Current Protocols in Immunology|February 3, 2015
ELISPOT Assay for Measurement of Antigen-Specific and Polyclonal Antibody ResponsesNils Lycke, Richard Coico
Current Opinion in Pharmacology|April 28, 2018
ADP-ribosylating enterotoxins as vaccine adjuvantsNils Lycke, Cristina Lebrero-Fernández
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient miceAli A Akhiani, Karin Schön, Nils Lycke
Infection and Immunity|July 20, 2007
Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infectionEllen Marks, Martina Verolin, Anneli Stensson, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Molecular Medicine|September 24, 2005
Targeted vaccine adjuvants based on modified cholera toxinNils Lycke
Nature Reviews. Immunology|July 26, 2012
Recent progress in mucosal vaccine development: potential and limitationsNils Lycke
Cellular Microbiology|December 18, 2003
From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOMNils Lycke
Immunology Letters|March 9, 2005
From toxin to adjuvant: basic mechanisms for the control of mucosal IgA immunity and toleranceNils Lycke
Annals of the New York Academy of Sciences|February 1, 2005
ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunityNils Lycke
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
A unique population of extrathymically derived alpha beta TCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tractMartina Johansson, Nils Lycke
Current Protocols in Immunology|February 3, 2015
ELISPOT Assay for Measurement of Antigen-Specific and Polyclonal Antibody ResponsesNils Lycke, Richard Coico
Current Opinion in Pharmacology|April 28, 2018
ADP-ribosylating enterotoxins as vaccine adjuvantsNils Lycke, Cristina Lebrero-Fernández
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient miceAli A Akhiani, Karin Schön, Nils Lycke
Infection and Immunity|July 20, 2007
Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infectionEllen Marks, Martina Verolin, Anneli Stensson, et al.
Pageof 5